Search

everythinglearnresearchcommunity

for

Search:↓

Spexin levels are lower in PCOS patients and linked to metabolic and hormonal issues.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Red light exposure can slow aging in mice by improving fat metabolism.

Many women with PCOS have hair loss, linked to age, hirsutism, sleep issues, and smoking.